IPSEN (OTCMKTS:IPSEY) Sees Unusually-High Trading Volume – What’s Next?

IPSEN (OTCMKTS:IPSEY) shares saw strong trading volume on Tuesday. Approximately 3,850 shares traded hands during mid-day trading, an increase of 95% from the average daily volume of 1,975 shares. The stock last traded at $42.35 and had previously closed at $43.56.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on IPSEY. Barclays upgraded IPSEN from a “strong sell” rating to a “hold” rating in a report on Thursday, September 17th. Jefferies Financial Group cut IPSEN from a “hold” rating to a “moderate sell” rating in a research note on Sunday, August 2nd. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, IPSEN currently has an average rating of “Hold”.

IPSEN Price Performance

The business’s 50-day moving average price is $44.08 and its 200 day moving average price is $45.12.

About IPSEN

Ipsen SA is a France-based biopharmaceutical company focused on developing and commercializing medicines for serious diseases. Its principal therapeutic areas are oncology, rare diseases and neuroscience, with operations spanning research, clinical development, manufacturing and commercial activities.

The company’s portfolio includes medicines such as Somatuline (lanreotide) for certain neuroendocrine tumors and rare endocrine conditions, Dysport (abobotulinumtoxinA) for therapeutic and aesthetic uses, and Onivyde (a liposomal formulation of irinotecan) for pancreatic cancer.